0001593968-22-001097.txt : 20220609 0001593968-22-001097.hdr.sgml : 20220609 20220609164225 ACCESSION NUMBER: 0001593968-22-001097 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220609 FILED AS OF DATE: 20220609 DATE AS OF CHANGE: 20220609 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Brannan Stephen K. CENTRAL INDEX KEY: 0001777631 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38958 FILM NUMBER: 221006460 MAIL ADDRESS: STREET 1: C/O KARUNA THERAPEUTICS, INC. STREET 2: 33 ARCH STREET, SUITE 3110 CITY: BOSTON STATE: MA ZIP: 02110 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Karuna Therapeutics, Inc. CENTRAL INDEX KEY: 0001771917 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 270605902 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 99 HIGH STREET STREET 2: 26TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 857-449-2244 MAIL ADDRESS: STREET 1: 99 HIGH STREET STREET 2: 26TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 4 1 primary_01.xml PRIMARY DOCUMENT X0306 4 2022-06-09 0001771917 Karuna Therapeutics, Inc. KRTX 0001777631 Brannan Stephen K. C/O KARUNA THERAPEUTICS, INC. 99 HIGH STREET, 26TH FLOOR BOSTON MA 02110 false true false false Chief Medical Officer Common Stock 2022-06-09 4 M false 5000 9.2 A 20000 D Common Stock 2022-06-09 4 S false 5000 110.9 D 15000 D Option (right to buy) 9.20 2022-06-09 4 M false 5000 0 D 2029-03-21 Common Stock 5000 49989 D The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 8, 2022. This option vests as to 12.5% of the shares underlying the option award on each six month anniversary following the vesting commencement date of March 21, 2019. /s/ Troy Ignelzi, Attorney-in-Fact 2022-06-09